Manuka Inc (fka MNKA)

[Rang]

just remember this part--i mean it's done alot on BB stocks,it's PR/IR paid--and it serves a need but it sends up a red flag compared to an actual research report or say gene Ingers DD..but the report is still very good etc

RJ FALKNER & COMPANY, INC. publishes research reports on small- and micro-cap companies. The information contained in our reports is based upon sources which we consider reliable but is not guaranteed by us, nor do such reports represent a solicitation to buy or sell the securities discussed therein. The information and opinions contained in our research reports are based upon publicly available information as of the date such reports are published. Readers of our reports should recognize that the information, projections, opinions, and/or conclusions contained in the reports may have changed since publication, and we assume no responsibility for updating the reports as a result of such changes. This report may include financial information that is not prepared in accordance with Generally Accepted Accounting Principles (GAAP) in the United States. Readers of this report should review the financial information provided by the subject company of this report in its 10-K, 10-Q and 8-K filings with the Securities and Exchange Commission.

Additional information on the companies discussed in our research reports is available upon request by contacting us at 800-377-9893. While we are paid by the companies that are the subject of our research reports for the provision of research coverage, we are not an agent of such companies, and all of the views expressed in our research reports accurately reflect our research analysts’ personal views about any and all of the subject securities or issuers. No part of our research analysts’ compensation was, is, or will be, directly or indirectly related to the specific recommendations or views expressed by such analysts in the research reports. All opinions and/or conclusions in our research reports were developed independently by the analysts writing the reports, unless otherwise stated. Our analyses of small- and micro-cap companies have been independently prepared by us, and any sales and/or earnings forecasts included in our research reports were independently prepared by RJ FALKNER & COMPANY, INC., unless otherwise stated, and are not endorsed by the managements of the companies which are the subject of our reports. Such sales and/or earnings forecasts were prepared based upon historical information that was available to the public as of the date of publication of the reports. Use of these reports may be subject to the applicable rules of certain self-regulatory organizations, and securities mentioned in the reports which are traded over-the-counter may not be cleared for sale in certain states.

RJ FALKNER & COMPANY, INC. and/or its employees, officers, affiliates or members of their families may have long or short positions in the securities discussed in the research reports (and/or options or warrants relating thereto) and may purchase and/or sell the securities or options/warrants from time to time in the open market or otherwise. RJ FALKNER & COMPANY, INC. derives its compensation from the provision of research reports and investor relations consulting services. RJ FALKNER & COMPANY, INC. currently receives a cash retainer of $3,000 per month from INKSURE TECHNOLOGIES INC. for the periodic publication and distribution of research reports on the company, along with certain investor relations services. An officer of RJ FALKNER & COMPANY, INC. currently owns 8,500 shares of INKS common stock and has been granted an option (expiring March 2015) to purchase up to 50,000 shares of INKS common stock at an exercise price of $1.40 per share.